drugset / Trial / NCT01338675
Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Chronic Granulomatous Disease(CGD)
NaSingle-groupOpen-labelTreatment
Summary
In this study the investigators plan to use optimal busulfan dose through pharmacokinetic study in stem cell transplantation of CGD patients.
Timeline
- Start
- 2011-01
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Busulfan | Small molecule | 80 mg/m2 | Intravenous |
| Subject | Busulfan | Small molecule | 120 mg/m2 | Intravenous |